The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion
Open accessAbstract
Long noncoding RNAs play a pivotal role in T-helper cell development but little is known about their roles in Treg differentiation and functions during the progression of hepatocellular carcinoma (HCC). Here, we show that lnc-epidermal growth factor receptor (EGFR) upregulation in Tregs correlates positively with the tumour size and expression of EGFR/Foxp3, but negatively with IFN-γ expression in patients and xenografted mouse models. Lnc-EGFR stimulates Treg differentiation, suppresses CTL activity and promotes HCC growth in an EGFR-dependent manner. Mechanistically, lnc-EGFR specifically binds to EGFR and blocks its interaction with and ubiquitination by c-CBL, stabilizing it and augmenting activation of itself and its downstream AP-1/NF-AT1 axis, which in turn elicits EGFR expression. Lnc-EGFR links an immunosuppressive state to cancer by promoting Treg cell differentiation, thus offering a potential therapeutic target for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Evolution and Functions of Long Noncoding RNAs
Ponting, C. P., Oliver, P. L., & Reik, W. (2009) · Cell · doi:10.1016/j.cell.2009.02.006 · Cited by 4,208
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Long non-coding RNAs: new players in cell differentiation and development
Fatica, A., & Bozzoni, I. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3606 · Cited by 2,980
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
Batista, P. J., & Chang, H. Y. (2013) · Cell · doi:10.1016/j.cell.2013.02.012 · Cited by 2,531
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Trépo, C., Chan, H. L. Y., & Lok, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60220-8 · Cited by 1,623
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Gao, Q., Qiu, S.-J., Fan, J., Zhou, J., Wang, X.-Y., Xiao, Y.-S., Xu, Y., Li, Y.-W., & Tang, Z.-Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,110
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
Wang, P., Xue, Y., Han, Y., Lin, L., Wu, C., Xu, S., Jiang, Z., Xu, J., Liu, Q., & Cao, X. (2014) · Science · doi:10.1126/science.1251456 · Cited by 1,105
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
Self-citationRecent progress in understanding, diagnosing, and treating hepatocellular carcinoma
Maluccio, M., & Covey, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21161 · Cited by 840
Woo, E. Y., Yeh, H., Chu, C. S., Schlienger, K., Carroll, R. G., Riley, J. L., Kaiser, L. R., & June, C. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4272 · Cited by 696
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Ichihara, F., Kono, K., Takahashi, A., Kawaida, H., Sugai, H., & Fujii, H. (2003) · PubMed · Cited by 489
Pathogenesis of hepatitis B virus—related hepatocellular carcinoma: Old and new paradigms
Bréchot, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.016 · Cited by 438
FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis
Kobayashi, N., Hiraoka, N., Yamagami, W., Ojima, H., Kanai, Y., Kosuge, T., Nakajima, A., & Hirohashi, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2363 · Cited by 431
Zaiss, D. M. W., van Loosdregt, J., Gorlani, A., Bekker, C. P. J., Gröne, A., Sibilia, M., van Bergen en Henegouwen, P. M. P., Roovers, R. C., Coffer, P. J., & Sijts, A. J. A. M. (2013) · Immunity · doi:10.1016/j.immuni.2012.09.023 · Cited by 418
Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia
Trimarchi, T., Bilal, E., Ntziachristos, P., Fabbri, G., Dalla-Favera, R., Tsirigos, A., & Aifantis, I. (2014) · Cell · doi:10.1016/j.cell.2014.05.049 · Cited by 412
Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W., et al. (2010) · Nature Genetics · doi:10.1038/ng.638 · Cited by 346
Self-citationTumor infiltrating lymphocytes in ovarian cancer
Santoiemma, P. P., & Powell, D. J. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1040960 · Cited by 337
Ranzani, V., Rossetti, G., Panzeri, I., Arrigoni, A., Bonnal, R. J. P., Curti, S., Gruarin, P., Provasi, E., Sugliano, E., Marconi, M., et al. (2015) · Nature Immunology · doi:10.1038/ni.3093 · Cited by 334
Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
Jiang, R., Tan, Z., Deng, L., Chen, Y., Xia, Y., Gao, Y., Wang, X., & Sun, B. (2011) · Hepatology · doi:10.1002/hep.24486 · Cited by 310
Self-citationTaylor, R. C., Patel, A., Panageas, K. S., Busam, K. J., & Brady, M. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9755 · Cited by 297
FOXP3+ regulatory T cells and their functional regulation
Li, Z., Li, D., Tsun, A., & Li, B. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.10 · Cited by 290
Hu, Y., Wang, J., Qian, J., Kong, X., Tang, J., Wang, Y., Chen, H., Hong, J., Zou, W., Chen, Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0686 · Cited by 282
Self-citationDifferentiation and function of Foxp3+ effector regulatory T cells
Cretney, E., Kallies, A., & Nutt, S. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.11.002 · Cited by 266
Long noncoding RNAs in innate and adaptive immunity
Fitzgerald, K. A., & Caffrey, D. R. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.001 · Cited by 218
Tang, J., Zhuo, H., Zhang, X., Jiang, R., Ji, J., Deng, L., Qian, X., Zhang, F., & Sun, B. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.518 · Cited by 195
Self-citationBruno, A., Ferlazzo, G., Albini, A., & Noonan, D. M. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju200 · Cited by 184
Blivet-Van Eggelpoël, M.-J., Chettouh, H., Fartoux, L., Aoudjehane, L., Barbu, V., Rey, C., Priam, S., Housset, C., Rosmorduc, O., & Desbois-Mouthon, C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.019 · Cited by 181
Treg(s) in Cancer: Friends or Foe?
Wolf, D. G. F., Sopper, S., Pircher, A., Gastl, G. A., & Wolf, A. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25016 · Cited by 169
Protein kinase C-η controls CTLA-4–mediated regulatory T cell function
Kong, K., Fu, G., Zhang, Y., Yokosuka, T., Casas, J., Canonigo-Balancio, A. J., Bécart, S., Kim, G., Yates, J. R., Kronenberg, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2866 · Cited by 147
Tanchot, C., Terme, M., Pere, H., Tran, T., Benhamouda, N., Strioga, M., Banissi, C., Galluzzi, L., Kroemer, G., & Tartour, E. (2013) · Cancer Microenvironment · doi:10.1007/s12307-012-0122-y · Cited by 138
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
Donkor, M. K., Sarkar, A., Savage, P. A., Franklin, R. A., Johnson, L. K., Jungbluth, A. A., Allison, J. P., & Li, M. O. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.019 · Cited by 130
cbl-b inhibits epidermal growth factor receptor signaling
Ettenberg, S. A., Keane, M., Nau, M. M., Frankel, M. E., Wang, L.-M., Pierce, J. H., & Lipkowitz, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202499 · Cited by 128
Potential of immunotherapy for hepatocellular carcinoma
Breous, E., & Thimme, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.013 · Cited by 127
Regulation of the Th1 Genomic Locus from Ifng through Tmevpg1 by T-bet
Collier, S. P., Henderson, M. A., Tossberg, J. T., & Aune, T. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401099 · Cited by 110
NK Cells and Cancer Immunoediting
Guillerey, C., & Smyth, M. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_446 · Cited by 110
Nuclear factor of activated T cells in cancer development and treatment
Shou, J., Jing, J., Xie, J., You, L., Zhao, J., Yao, J., Han, W., & Pan, H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.005 · Cited by 106
The Emerging Protumor Role of γδ T Lymphocytes: Implications for Cancer Immunotherapy
Rei, M., Pennington, D. J., & Silva‐Santos, B. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3228 · Cited by 95
Gao, Y., Yao, A., Zhang, W., Lu, S., Yu, Y., Deng, L., Yin, A., Xia, Y., Sun, B., & Wang, X. (2010) · Oncogene · doi:10.1038/onc.2010.38 · Cited by 93
Self-citationChew, V., Tow, C., Huang, C. W., Bard-Chapeau, E. A., Copeland, N. G., Jenkins, N. A., Weber, A., Lim, K. H., Toh, H. C., Heikenwälder, M. F., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs436 · Cited by 92
B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets
Kuang, D., Xiao, C., Zhao, Q., Chen, M., Li, X., Liu, R., Yuan, W., Ouyang, F., Chen, D., Wu, Y., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74381 · Cited by 85
Matrilysin(MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells
Yokoyama, Y., Grünebach, F., Schmidt, S. M., Heine, A., Häntschel, M., Stevanović, S., Rammensee, H., & Brossart, P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4041 · Cited by 81
Selective function of PKC-theta in T cells.
Manicassamy, S., Gupta, S., & Sun, Z. (2006) · PubMed · Cited by 73
Schmidt, A., Oberle, N., Weiss, E., Vobis, D., Frischbutter, S., Baumgrass, R., Falk, C. S., Haag, M., Brügger, B., Lin, H., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2002179 · Cited by 71
Gregori, S., Mangia, P., Bacchetta, R., Tresoldi, E., Kolbinger, F., Traversari, C., Carballido, J. M., de Vries, J. E., Korthäuer, U., & Roncarolo, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040912 · Cited by 64
Digital Genomic Quantification of Tumor-Infiltrating Lymphocytes
Robins, H. S., Ericson, N. G., Guenthoer, J., O'Briant, K. C., Tewari, M., Drescher, C. W., & Bielas, J. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007247 · Cited by 58
Dai, K., Huang, L., Chen, J., Yang, L., & Gong, Z. (2014) · Immunology · doi:10.1111/imm.12400 · Cited by 45
Research works printed but not linked: 6
- Lau, E. & Non-coding, R. N. A. Zooming in on lncRNA functions. Nat. Rev. Genet. 15, 574–575 (2014). · doi:10.1038/nrg3795
- Singavi, A. K., Harrington, A. M. & Fenske, T. S. Post-transplant lymphoproliferative disorders. Cancer Treatment Res. 165, 305–327 (2015). · doi:10.1007/978-3-319-13150-4_13
- Huang, B. Long non-coding RNA: dancing on immune stage. Science China Life sciences 57, 643–644 (2014). · DOI
- Wu, A., Ericson, K., Chao, W. & Low, W. C. NFAT and AP1 are essential for the expression of a glioblastoma multiforme related IL-13Ra2 transcript. Cell. Oncol. 32, 313–329 (2010).
- Cheng, A. L. et al. Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: a phase 2 randomized study. J. Hepatol. 63, 896–904 (2015). · doi:10.1016/j.jhep.2015.06.001
- David, D. et al. Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood 91, 165–172 (1998). · doi:10.1182/blood.v91.1.165
Cited by
Long noncoding RNAs in cancer metastasis
Liu, S. J., Dang, H. X., Lim, D. A., Feng, F. Y., & Maher, C. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00353-1 · Cited by 648
Ratti, M., Lampis, A., Ghidini, M., Salati, M., Mirchev, M. B., Valeri, N., & Hahne, J. C. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00717-x · Cited by 606
The role of long noncoding RNAs in hepatocellular carcinoma
Huang, Z., Zhou, J.-K., Peng, Y., He, W., & Huang, C. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01188-4 · Cited by 511
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Wu, Q., You, L., Nepovimova, E., Heger, Z., Wu, W., Kuca, K., & Adam, V. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01292-6 · Cited by 485
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
Huang, D., Chen, J., Yang, L., Ouyang, Q., Li, J., Lao, L., Zhao, J., Liu, J., Lu, Y., Xing, Y., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0207-y · Cited by 448
Metadata
- Authors
- Jiang, R., Tang, J., Chen, Y., Deng, L., Ji, J., Xie, Y., Wang, K., Jia, W., Chu, W.-M., & Sun, B.
- Venue
- Nature Communications
- Published
- 2017-05-25
- Volume
- 8
- Issue
- 1
- Pages
- 15129-15129
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2619618599
- Cited by
- 343
- References
- 53
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.